Belluscura Share Discussion Threads

[owenski] 09/5/2023 17:16

As per Masurenguy's post 423;

There do seem to be a lot of portable generators on the market, Belluscura's come in at $1800 - $2000 if I recall, there are a lot of others on the market for substantially less than this, although quality and % oxygen delivery does vary.

Bell, aint the only game in town, will continue to watch.

[masurenguy] 09/5/2023 16:12

This remains an interesting business with considerable potential but it is difficult to gauge how they compare with their competition. I'm also uncertain why they listed here instead of the NASDAQ.

Fund raising so far
IPO @45p in May 21.
Further placing @85p in May 22.
Broker Option exercised @37.7p in Feb 22.

It looks like a further fund raising will be necessary this year so I remain on the sidelines waiting to see when this takes place and at what price.

[danmart2] 07/5/2023 21:32

Agree with your position, I expect them to have to raise again.

The next raise should be the last raise if the management have anything about them; they need to demonstrate cost control and a clear path to profits.

[owenski] 07/5/2023 12:23

Year end TU was back in January, how long does it take to publish results, I find it an issue if a company can't get it's results out promptly, last year they were published in February and now we're into May.

From January TU -

"By 31 December 2022 the Company had shipped or received orders for 2,850 X-PLOR units with 1,226 units being shipped in 2022 (2021: 377). As at the year end, the Adjusted EBITDA1 loss is anticipated to be in line with market expectations and retained cash balances of $1.8 million, which together with inventory and inventory deposits, amounted to $11.9 million."

They've got potentially $11.9m in inventory etc which could be unwound into sold stock, but only $1.8m in cash as of Dec. Am thinking funds might be getting tight as they're still burning through a lot of cash.

Would like to see where they're at presently with sales and cash on the books and whether they're going to raise again before I commit here.

If this turns out to be a decent growth business, then 45m market cap might not be too demanding an entry point, but I suspect they might raise a bit, if so, at what price.

I'll wait on this for now as I need a bit more progress detail inc. financials. I notice that cost of sales seems to grow with actual sales, and admin costs have shot up, would like to be able to start to gauge if and when the costs start to 'fix' so that one can calculate upward volumes sold actually makes for an attractive bottom line calculation. Still early days here though I guess.

[owenski] 07/5/2023 12:02

Current M.cap @ 37p = 45.6m

[masurenguy] 05/4/2023 09:05

Belluscura products do not feature in this NCO survey. Any views?



On my watchlist but no position yet.

[cheshire] 03/4/2023 08:23

I think Belluscura could well be a takeover target by one of the larger medical supplies manufacturers. Onwards and upwards

[btgman] 03/4/2023 07:40

Belluscura is significantly undervalued for anyone who is prepared to look forward.

I like this

Orders of the X-PLOR portable concentrator continue to grow, as new distributors are brought on board, and are in line with company expectations.

Inline with expectations being the key.

AIMHO
GLA
BTG

[brummy_git] 03/4/2023 07:14

Encouraging trading update from next generation, medical devices firm Belluscura today.

All the details here.

[danmart2] 28/3/2023 19:19

They will need more funding
The Chinese manufacturer will need close control and support
Previous sales where pathetic

I think this falls below 28p before any recovery

[pugugly] 28/3/2023 12:23

Mr Market does not buy the story - new one year breakout to the downside.

[rovi70] 22/3/2023 09:50

Breath of fresh air.

[buywell3] 14/3/2023 20:01

Hyperbaric Oxygen Treatment Helps Long Covid Patients, Study Says




Long Covid news from Australia

March 14th 2023

Brain similarities for long COVID, chronic fatigue

Medical imaging has shown similarities between the brains of people with long COVID-19 and those with chronic fatigue syndrome.

Scans showed the brainstem was significantly larger in myalgic encephalomyelitis/chronic fatigue syndrome patients and long COVID patients, compared with those who did not have the same ailments, lead study author Kiran Thapaliya said.






World's strongest MRI investigates COVID and myalgic encephalomyelitis/chronic fatigue impacts on the brain







More studies are coming in regarding Long Covid and treatment therapies that can be used

Hyperbaric Oxygen Treatment Helps Long Covid Patients, Study Says



IMO the breathing of oxygen via a CPAP device within a decompression chamber has been proved to work

Results published by Scientific Reports revealed substantial improvements in damaged brain tissue and functional cognition for the participants who breathed the pure oxygen. Most also said they felt back to “normal.”






watch the video





In the UK the ONS stats and Long Covid facts




In the US with over 25 Million suffering from Long Covid one would expect a similar outcome --- namely:

A growing proportion of this total is made up by people who have had symptoms for a long period.

Covid-19 is not going to go away therefore Long Covid is NOT going to go away either --- a treatment therapy is needed

Is HBOT it ?


dyor

[buywell3] 07/3/2023 08:02

Long COVID linked to lower brain oxygen levels, cognitive problems and psychiatric symptoms

WEDNESDAY, MARCH 1, 2023




March 6th 2023

Chest pain warning after Covid as health problems can last 'years', study finds
A new study in the US into the long-term effects of Covid has found that people are more likely to have chest pains in the six months to a year after having had the virus






IMO lower blood oxygen saturation levels is the issue here affecting all body organs



dyor

[owenski] 24/2/2023 14:43

I guess they had to go for the loan note route, would prefer capital raise as one can wait and watch on the share price action if one isn't a holder - no pain, but I guess raising capital at present on an already falling share price they would've been hammered.

Loan notes appear unsecured, but as you said - 500k p/a, or a million if they issue a further tranch - likely. Considering they're not making a profit they must have some conviction on the business.

[pugugly] 24/2/2023 08:10

owenski - Thanks for that and especially note re loans at scalpers coupon of 10%, OUCH- £500k p/a. I would not mind that sort of interest but (imo) possible risk to lender unless a lien over assets - Will have to check if after some DD consider dipping toe into the water.

[owenski] 24/2/2023 07:42

123m shares in issue, therefore, market cap at present is just shy of £53m

[owenski] 24/2/2023 07:38

They had an end of year TU in Jan. Last year results were on the 22nd Feb. Still no announcement of results, how long does it take??

They're in hock for 5m @ 10% coupon already with another 5m that they're likely to issue. The actual production and unit sales need to be good to justify this debt load and an already pricey market cap considering they'll still be burning cash this year.

[pugugly] 24/2/2023 07:34

ADVFN market cap wrong - Should be more like £52M.
Do all agree?

[danmart2] 24/2/2023 07:32

Difficult RNS to evaluate as no doubt the detail is key,

It’s all about the fee / percentage / volume the 3rd party seller takes away.

More sales are great but not if your making a few cents

[buywell3] 24/2/2023 07:23

GoodRx is a listed $ 2 Billion company

Should give US sales some impetus imo

[mr.oz] 23/2/2023 15:11

Number of units sold and how the transfer to Chinese production is going of interest



"Analysts expect great things from Belluscura. Last year, Rauker sold 377 pieces of kit. This year, sales of 2000 are forecast, rising to 18,000 next year and 70,000 by 2025.

[owenski] 22/2/2023 12:50

Results were out on 22 Feb. last year.